A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
Moreno-González, G, Mussetti, A, Albasanz-Puig, A, Salvador, I, Sureda, A, Gudiol, C, Salazar, R, Marin, M, Garcia, M, Navarro, V, de la Haba Vaca, I, Coma, E, Sanz-Linares, G, Dura, X, Fontanals, S, Serrano, G, Cruz, C, Mañez, R
Published in Current controlled trials in cardiovascular medicine (05.02.2021)
Published in Current controlled trials in cardiovascular medicine (05.02.2021)
Get full text
Journal Article